James Malcolm Heather, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Antigen, T-Cell | 8 | 2022 | 2498 | 1.420 |
Why?
|
High-Throughput Nucleotide Sequencing | 9 | 2021 | 3698 | 0.770 |
Why?
|
Phosphopeptides | 1 | 2019 | 241 | 0.690 |
Why?
|
Sequence Analysis, DNA | 4 | 2018 | 4916 | 0.620 |
Why?
|
Software | 5 | 2022 | 4367 | 0.530 |
Why?
|
HLA Antigens | 1 | 2019 | 1552 | 0.490 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 5 | 2020 | 812 | 0.410 |
Why?
|
Complementarity Determining Regions | 2 | 2018 | 160 | 0.320 |
Why?
|
T-Lymphocytes | 7 | 2021 | 10376 | 0.320 |
Why?
|
Common Variable Immunodeficiency | 2 | 2019 | 104 | 0.310 |
Why?
|
Proteomics | 1 | 2019 | 3268 | 0.310 |
Why?
|
Immunoconjugates | 2 | 2022 | 840 | 0.250 |
Why?
|
Genetic Variation | 1 | 2018 | 6664 | 0.230 |
Why?
|
DNA, Complementary | 2 | 2022 | 2095 | 0.200 |
Why?
|
HIV Long-Term Survivors | 1 | 2021 | 126 | 0.200 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2019 | 89 | 0.190 |
Why?
|
Cytomegalovirus | 2 | 2022 | 692 | 0.180 |
Why?
|
Antibody Diversity | 1 | 2018 | 73 | 0.180 |
Why?
|
Immunologic Memory | 3 | 2020 | 1385 | 0.160 |
Why?
|
Chromosomes, Human, X | 1 | 2019 | 311 | 0.160 |
Why?
|
Antigens | 2 | 2020 | 1514 | 0.160 |
Why?
|
Immunoglobulin Variable Region | 1 | 2018 | 421 | 0.160 |
Why?
|
X Chromosome Inactivation | 1 | 2019 | 237 | 0.160 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2019 | 512 | 0.160 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1056 | 0.150 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 762 | 0.150 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2018 | 337 | 0.140 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2020 | 876 | 0.140 |
Why?
|
Antibodies | 2 | 2022 | 2442 | 0.140 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1928 | 0.130 |
Why?
|
Lymphocyte Activation | 3 | 2021 | 5892 | 0.130 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2015 | 136 | 0.130 |
Why?
|
Mice, SCID | 1 | 2019 | 2845 | 0.120 |
Why?
|
Antigen Presentation | 1 | 2019 | 1301 | 0.120 |
Why?
|
Base Sequence | 2 | 2022 | 13317 | 0.120 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2017 | 626 | 0.120 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2249 | 0.110 |
Why?
|
Transplantation, Heterologous | 1 | 2019 | 2441 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4266 | 0.100 |
Why?
|
Nanotechnology | 1 | 2015 | 709 | 0.090 |
Why?
|
Computational Biology | 3 | 2020 | 3568 | 0.090 |
Why?
|
Amino Acid Sequence | 1 | 2022 | 14243 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2019 | 2019 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2019 | 3018 | 0.090 |
Why?
|
History, 21st Century | 1 | 2015 | 1569 | 0.090 |
Why?
|
Leukocytes | 1 | 2017 | 2103 | 0.080 |
Why?
|
Phosphorylation | 1 | 2019 | 8744 | 0.080 |
Why?
|
Cell Line | 2 | 2019 | 16693 | 0.080 |
Why?
|
History, 20th Century | 1 | 2015 | 2830 | 0.080 |
Why?
|
Mice, Knockout | 2 | 2019 | 15258 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2022 | 19537 | 0.070 |
Why?
|
Algorithms | 4 | 2021 | 13716 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6294 | 0.070 |
Why?
|
Anti-HIV Agents | 1 | 2021 | 4056 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4750 | 0.070 |
Why?
|
DNA | 1 | 2019 | 7166 | 0.070 |
Why?
|
Immunophenotyping | 2 | 2019 | 1904 | 0.060 |
Why?
|
Humans | 18 | 2022 | 717280 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5152 | 0.050 |
Why?
|
Mice | 4 | 2022 | 81128 | 0.050 |
Why?
|
Neoplasms | 2 | 2020 | 20572 | 0.050 |
Why?
|
Inflammation | 1 | 2019 | 10116 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 686 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9532 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2020 | 780 | 0.040 |
Why?
|
B-Lymphocyte Subsets | 1 | 2019 | 252 | 0.040 |
Why?
|
Endodeoxyribonucleases | 1 | 2019 | 168 | 0.040 |
Why?
|
Matrix Metalloproteinases | 1 | 2020 | 407 | 0.040 |
Why?
|
Animals | 5 | 2022 | 170894 | 0.040 |
Why?
|
Gene Library | 1 | 2020 | 1093 | 0.040 |
Why?
|
Viruses | 1 | 2020 | 358 | 0.040 |
Why?
|
Receptors, Complement 3d | 1 | 2016 | 135 | 0.040 |
Why?
|
Epitope Mapping | 1 | 2017 | 304 | 0.040 |
Why?
|
Immunomodulation | 1 | 2020 | 535 | 0.040 |
Why?
|
Epitopes | 1 | 2022 | 2657 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 15673 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2020 | 702 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2019 | 584 | 0.030 |
Why?
|
Organ Specificity | 1 | 2020 | 2049 | 0.030 |
Why?
|
Immunoglobulin Class Switching | 1 | 2016 | 295 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 2016 | 637 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1760 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2020 | 1426 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2019 | 1061 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 20097 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1920 | 0.030 |
Why?
|
Autoantigens | 1 | 2017 | 911 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 21811 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1038 | 0.030 |
Why?
|
Thymus Gland | 1 | 2016 | 1323 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2020 | 1909 | 0.030 |
Why?
|
Amino Acids | 1 | 2017 | 1754 | 0.030 |
Why?
|
DNA Primers | 1 | 2015 | 2999 | 0.030 |
Why?
|
Zebrafish | 1 | 2022 | 3030 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1800 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2046 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4438 | 0.020 |
Why?
|
Autoimmunity | 1 | 2017 | 1335 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2018 | 2827 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2161 | 0.020 |
Why?
|
Homeostasis | 1 | 2017 | 3344 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4102 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 6134 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2017 | 3433 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4383 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2021 | 62344 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16404 | 0.010 |
Why?
|
Skin | 1 | 2017 | 4355 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16989 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9892 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2016 | 4928 | 0.010 |
Why?
|
Melanoma | 1 | 2020 | 5260 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11762 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 215054 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 23409 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18798 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 24744 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 41094 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22929 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 12435 | 0.010 |
Why?
|
Female | 3 | 2022 | 377934 | 0.010 |
Why?
|
Infant | 1 | 2018 | 34574 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 41221 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 56249 | 0.010 |
Why?
|
Child | 1 | 2018 | 74388 | 0.010 |
Why?
|
Aged | 1 | 2019 | 162862 | 0.000 |
Why?
|
Adult | 1 | 2019 | 212470 | 0.000 |
Why?
|
Male | 1 | 2021 | 351399 | 0.000 |
Why?
|